Sirt1 activation promotes chronic granulocytic leukemia (CML) cell survival, and proliferation is associated with the deacetylation of multiple SIRT1 substrates, including FoxO1, p53, and KU70. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.